Endocrinology - Obesity News & Articles

MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.

Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Endocrinology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

Articles

Latest (4) Full Text Articles (403) Focus on Diabetes

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

1 Steroid hormone profiles in prepubertal obese children before and after weight loss Journal of Clinical Endocrinology and Metabolism, May 24, 2013 Clinical Article

2 Serum visfatin levels and metabolic syndrome criteria in obese female subjects Diabetes/Metabolism Research and Reviews, May 24, 2013 Review Article

3 Limited value of routine microalbuminuria assessment in multi-ethnic obese children Pediatric Nephrology, May 24, 2013 Clinical Article

4 Effects of a weight-gain restriction programme for obese pregnant women on sickness absence and pregnancy benefits Full Text Scandinavian Journal of Primary Health Care, May 24, 2013 Clinical Article

Prior Articles

5 Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation Diabetic Medicine, May 23, 2013

6 Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a one-year lifestyle intervention in viscerally obese men Diabetes Care, May 23, 2013 Review Article

7 Concomitant changes in sleep duration and body weight and body composition during weight loss and 3-mo weight maintenance American Journal of Clinical Nutrition, May 23, 2013 Review Article

8 Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects Diabetic Medicine, May 23, 2013 Clinical Article

9 Hepatic steatosis and severity-related factors in obese children Journal of Gastroenterology and Hepatology, May 23, 2013 Review Article

10 Laparoscopic removal of poor outcome gastric banding with concomitant sleeve gastrectomy Obesity Surgery, May 23, 2013 Review Article

11 Clinical impact of a 6-week preoperative very low calorie diet on body weight and liver size in morbidly obese patients Obesity Surgery, May 23, 2013 Clinical Article

12 Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes Clinical Endocrinology, May 22, 2013 Review Article

13 Metabolic inflammation: Connecting obesity and insulin resistance Annals of Medicine, May 22, 2013 Review Article Clinical Article

14 ‘Small changes' to diet and physical activity behaviors for weight management Obesity Facts, May 22, 2013 Review Article

15 Change in proportional protein intake in a 10-week energy-restricted low- or high-fat diet, in relation to changes in body size and metabolic factors Obesity Facts, May 22, 2013 Clinical Article

16 Obesity-related chronic kidney disease is associated with spleen-derived IL-10 Nephrology Dialysis Transplantation, May 22, 2013 Review Article

17 Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients Obesity Surgery, May 22, 2013 Review Article

18 Multifactorial intervention for children with asthma and overweight (Mikado): study design of a randomised controlled trial Full Text BMC Public Health, May 22, 2013 Clinical Article

19 Weight Management Interventions Targeting Young Women: A Systematic Review Journal of the Academy of Nutrition and Dietetics, May 21, 2013 Evidence Based Medicine Review Article Clinical Article

20 Participants’ Explanatory Model of Being Overweight and Their Experiences of 2 Weight Loss Interventions Full Text Annals of Family Medicine, May 21, 2013 Review Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Endocrinology

Pioglitazone can reduce the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72%, but it was also associated with significant weight gain and edema
The most commonly reported adverse event associated with Janumet in the treatment of type 2 diabetes is diarrhea, followed by upper respiratory tract infection and headache
Maturity-onset diabetes of the young (MODY)3 can be treated with sulfonylureas with excellent results for decades

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Endocrinology

Regulatory protein identified in T1DM

As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.

Read the article summary

Statins increase risk of DM in postmenopausal women

As reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up

Read the article summary

Determining the basal insulin dosage in T2DM

Anthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Endocrinology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Endocrinology - Obesity News & Articles

Articles

Prior Articles

Clinical Pearls in Endocrinology

Highlights in Endocrinology

Regulatory protein identified in T1DM

Statins increase risk of DM in postmenopausal women

Determining the basal insulin dosage in T2DM

Most Popular Endocrinology Articles

Other Topics in Endocrinology